Vima Therapeutics: Funding, Investors & Team (Sep 2026)
Vima Therapeutics operates as a biotechnology company.Vima Therapeutics creates a new era in treatments for dystonia and related movement disorders.
Vima Therapeutics has raised $40.0M across 1 funding round on record, the most recent a Series A of $40.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vima Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Vima Therapeutics Funding Rounds
Vima Therapeutics Founders and Leadership Team
Contact details for the Vima Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Vima Therapeutics Funding Compared to Other Biotechnology Startups
Vima Therapeutics' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vima Therapeutics in Biotechnology and Cambridge
Companies Similar to Vima Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Vima Therapeutics Funding FAQs
What does Vima Therapeutics do?
Vima Therapeutics operates as a biotechnology company.Vima Therapeutics creates a new era in treatments for dystonia and related movement disorders.
How much funding has Vima Therapeutics raised?
Vima Therapeutics has raised $40.0M across 1 round on record. The most recent is a Series A of $40.0M announced in Mar 2026.
When did Vima Therapeutics last raise funding?
Vima Therapeutics' most recent funding round on record is a Series A of $40.0M, announced in Mar 2026.
Who founded Vima Therapeutics?
FundedIQ lists Bernard Ravina (Founder) at Vima Therapeutics.
Where is Vima Therapeutics headquartered?
Vima Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Vima Therapeutics have?
Vima Therapeutics is in the 11-50 employee band.
How does Vima Therapeutics' funding compare to other Biotechnology startups?
Vima Therapeutics' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Vima Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vima Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.